Screener
Maze Therapeutics MAZE Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
FAQ
- What is Maze Therapeutics's total equity?
- Maze Therapeutics (MAZE) reported total equity of $453.12M in Q2 2026.
- How has Maze Therapeutics's total equity changed year-over-year?
- Maze Therapeutics's total equity increased by 72.8% year-over-year, from $262.24M to $453.12M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Maze Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude